Are you above the legal age to view this content in your province/state?

Home / Cannabis Stock Market / Cannabis Stock Watchlist: New York, Aphria, Sundial Growers

Cannabis Stock Watchlist: New York, Aphria, Sundial Growers

Cannabis Stock Watchlist: New York, Aphria, Sundial Growers

This story originally appeared on  Thestreet.

See how cannabis stocks like Sundial Growers, Trulieve and Tilray performed last week after New York agreed to a deal to legalize marijuana use.

The cannabis sector was down this past week as investors turned their backs on speculative stock plays and looked at reopening stocks to buy as the U.S. gets closer to fully reopening its economy.

Cannabis stocks received a boost this past week when New York agreed to a deal to become the 16th state to legalize recreational marijuana. 

Cannabis stocks were pointing towards starting the week higher with the benchmark ETFMG Alternative Harvest ETF  (MJ) – Get Report rising after closing out Friday’s session down 0.4%. Shares are down Monday.

Real Money’s Debra Borchardt shared this past week that picking the best cannabis SPACs boils down to picking the right team including one from hip-hop legend Jay-Z.

Here is a list of cannabis stocks to watch and their performance from the past week by the percentage change at the close of trading on Mar. 26. 

Tilray Inc. | Decreased -12.9%

Tilray  (TLRY) – Get Report shares had a rough week last week and closed Friday’s session down more than 3%, but the stock is the best performing cannabis stock in 2021, rising more than 170% this quarter. 

Aphria Inc | Decreased -10.39%

Aphria  (APHA) – Get Report shares were also down big this week, but the stock has also been one of the best cannabis stocks so far in 2021. Shares are up more than 150% after agreeing to merge with Tilray in a deal expected to close in the second quarter. 

Sundial Growers Inc. | Decreased -24.16%

Sundial Growers  (SNDL) – Get Report had a rough start last week after the Calgary-based company filed a share sale prospectus with the SEC where it would create up to $800 million in new common stock to sell. 

Trulieve Cannabis Corp. | Decreased -4.2%

Trulieve  (TCNNF) – Get Report announced fourth quarter results that topped analyst estimates with record revenue of $521.5 million for the year with a $63 million profit. Analysts at Canaccord Genuity increased the company’s price target to C$87 from C$75 in a bullish note last week. 

Curaleaf Holdings Inc | Decreased -6.4%

Curaleaf  (CURLF)  announced the launch of Select Squeeze last week, a fast-acting THC-infused beverage enhancer. Select Squeeze is an additive that can transform any beverage into a THC-infused beverage. 

GrowGeneration | Decreased -19.68%

GrowGeneration  (GRWG) – Get Report shares were down this past week after the hydroponic and organic gardening store retailer posted record full-year sales and said it sees solid first-quarter sales.


Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.

Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.

Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.

Investment Value Finders is intended for those 21+ years of age only!

Check Also

FSD Pharma Announces Closing of Lucid Psycheceuticals Acquisition

FSD Pharma Announces Closing of Lucid Psycheceuticals Acquisition

Lucid Adds Potential for Neurodegenerative Disease Treatments and Mental Health in a Novel Way TORONTO–(BUSINESS …